Wilson Sonsini represented lead investors SR One and Norwest in the transaction. Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision...
Rezo Therapeutics’ $78 Million Series A Financing
Swell Energy’s $120 Million Fundraise
Wilson Sonsini Goodrich & Rosati advised Swell while Locke Lord advised Greenbacker Capital Management, LLC. Energy management and smart grid solutions provider Swell Energy announced that...
AppHub’s Acquisition of REVIEWS.io
Wilson Sonsini advised REVIEWS.io on the deal, while Kirkland & Ellis advised AppHub. AppHub, an ecommerce enablement platform, announced it acquired REVIEWS.io. REVIEWS.io helps businesses enhance...
EV Realty’s $28 Million Investment Round
Wilson Sonsini Goodrich & Rosati represented EV Realty on the deal. EV Realty, an EV infrastructure development platform purpose-built to maximize electric power availability for critical...
MBX Biosciences’ $115 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on the deal while WilmerHale advised Wellington Management. MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision...
Zenas BioPharma’s $118 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised lead investor Enavate Sciences and new investor Longitude Capital in the financing. Global pharmaceutical company Zenas BioPharma announced a $118...
Yakoa’s $4.8 Million Fundraise for NFT Fraud Detection
Wilson Sonsini Goodrich & Rosati advised Yakoa on the transaction. NFT fraud detection network Yakoa announced that it had raised $4.8 million to help the company...
Zibuyu Group Limited’s HK$197.7 Million IPO
Harneys acted as Cayman Islands counsel to Zibuyu Group Limited on the listing. Tian Yuan Law Firm LLP provided Hong Kong legal advice to Zibuyu and...
ATP’s Launch of Ascidian Therapeutics
Wilson Sonsini Goodrich & Rosati advised Ascidian Therapeutics on the deal. Life sciences venture capital firm ATP announced the launch of new biotechnology company Ascidian Therapeutics....
Alto Neuroscience’s $35 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Alto Neuroscience on the deal. Alto Neuroscience announced the closing of a $35 million Series B financing led by Lightswitch...
Insilico Medicine’s Research Collaboration with Sanofi
Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the transaction. Insilico Medicine, a clinical-stage artificial intelligence-driven drug discovery company, announced a multi-year, multi-target strategic research...
Bruker’s Acquisition of Inscopix
Wilson Sonsini Goodrich & Rosati advised Inscopix on the deal. Bruker Corporation, a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions,...